MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Systematic mapping of Parkinson’s disease gene interactions

    P. Antony, J. Forster, O. Kondratyeva, S. Köglsberger, R. Krüger (Belvaux, Luxembourg)

    Objective: Here, we aim to identify functional interactions between the Parkinson’s disease-associated genes. Background: Understanding how genes interact to produce a given phenotype is a…
  • 2022 International Congress

    Molecular alterations and pathological remodeling of colonic wall in patients with Parkinson’s disease

    G. Bellini, G. Palermo, D. Frosini, L. Benvenuti, C. Pellegrini, M. Bellini, N. Bernardini, M. Fornai, R. Ceravolo (Pisa, Italy)

    Objective: To evaluate, in an integrated manner, changes in faecal microbiota composition, morpho-functional alterations of the colonic mucosal barrier and changes of inflammatory markers in…
  • 2022 International Congress

    Sleep stability, arousals and cycle structure in alfa-synucleinopathies: a comparative study between isolated REM sleep behaviour disorder (iRBD), Parkinson’s Disease (PD) and Dementia with Lewy Bodies (DLB)

    M. Magriço, P. Bugalho (Lisboa, Portugal)

    Objective: To compare sleep stability, arousals and sleep cycle structure between two sets of diagnosis: iRBD vs PD vs DLB; patients with RBD (RBD+) vs…
  • 2022 International Congress

    Intermuscular coherence as a biomarker of subthalamic nucleus deep brain stimulation efficacy in Parkinson’s disease

    S. Lagerweij, J. van Zijl, T. van Laar, D. Oterdoom, J. van Dijk, M. Tijssen, J. Elting (Groningen, Netherlands)

    Objective: Deep brain stimulation of the subthalamic nucleus (STN-DBS) is an established treatment in advanced Parkinson’s disease (PD). However, the clinical outcome after STN-DBS is…
  • 2022 International Congress

    Frequency of non-motor symptoms in GBA-PD may differ in carriers of mild vs. severe pathogenic variants

    T. Usnich, N. Brüggemann, M. Olmedillas, N. Schell, I. Csoti, S. Ertan, D. Gruber, S. Zittel, E. Sammler, S. Isaacson, A. Kühn, D. Pedrosa, K. Reetz, A. Sah, M. Kasten, P. Bauer, C. Klein (Lübeck, Germany)

    Objective: Parkinson's disease (PD) patients with pathogenic variants in the GBA (glucocerebrosidase) gene (GBA-PD) were reported to exhibit a younger age at onset, faster progression…
  • 2022 International Congress

    LFP beta frequency OFF-ON shift in subthalamic nucleus in Parkinson’s disease

    K. Sayfulina, V. Filyushkina, A. Gamaleya, E. Belova, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

    Objective: The aim of the current study is to investigate the frequency characteristics of beta activity in Parkinson’s disease. We hypothesized that beta peak central…
  • 2022 International Congress

    Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy

    A. Quattrone, M. Crasà, M. Morelli, B. Vescio, A. Augimeri, V. Gramigna, A. Quattrone (Catanzaro, Italy)

    Objective: Objective: PSP patients typically show reduced amplitude and velocity of vertical saccades, but saccadic abnormalities have also been reported in PD. We investigated the…
  • 2022 International Congress

    Levodopa-carbidopa intestinal gel infusion and long-term tolerability in Parkinson’s: multicentre, international 13-year follow-up data

    V. Leta, L. Batzu, L. Williams, S. Waller, F. Garri, K. Rukavina, M. Parry, S. Jones, J. Griffith, N. Jeyakumar, M. Scharfenort, P. Odin, V. Metta, G. Chung-Faye, P. Dubois, T. Marshall, A. Zecchinelli, F. Del Sorbo, V. Viljaharju, E. Pekkonen, A. Antonini, V. Fung, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To evaluate the long-term range and nature of Levodopa-carbidopa intestinal gel (LCIG) infusion-related complications in people with Parkinson’s (PwP). Background: LCIG infusion is an…
  • 2022 International Congress

    EEG power-spectra parametrization and cognitive ability in Parkinson’s disease

    R. Shoorangiz, N. Slater, G. Hall-Mcmaster, E. Peterson, L. Livingston, S. Grenfell, K. Clifford, A. Harris, I. Kirk, L. Tippett, R. Jones, T. Anderson, T. Melzer, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To parametrize EEG power-spectra and examine the association of periodic and aperiodic components with cognitive ability in Parkinson's disease (PD). Background: PD is associated…
  • 2022 International Congress

    At-home prolonged adaptive deep brain stimulation improves symptoms and reduces side effects in Parkinson’s disease

    C. Oehrn, S. Cernera, L. Hammer, M. Shcherbakova, A. Hahn, R. Gilron, C. Smyth, R. Wilt, S. Little, P. Starr (SAN FRANCISCO, USA)

    Objective: Objective: To assess the effect of at-home adaptive deep brain stimulation (aDBS) on symptoms and treatment-associated side-effects in one patient with Parkinson’s disease (PD),…
  • « Previous Page
  • 1
  • …
  • 244
  • 245
  • 246
  • 247
  • 248
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley